Science & Technology Partners’s Eli Lilly LLY Stock Holding History

Science & Technology Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.4M	Buy	+19,550	New	+$20M	3.95%	11

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Science & Technology Partners's LLY Position: Q2 2026 in Review

Science & Technology Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 19,550 shares worth $23.4M. The stake represents 3.95% of the portfolio and ranks #11 among its holdings.

4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Science & Technology Partners held 19,550 shares of Eli Lilly worth $23.4M as of Q2 2026.
Eli Lilly was a new Science & Technology Partners position in Q2 2026.
Eli Lilly made up 3.95% of Science & Technology Partners's portfolio in Q2 2026, its #11 holding.
4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Science & Technology Partners's 13F filing for Q2 2026, filed 14 Aug 2026.